PharmaShots | Incisive News in 3 Shots

Subscribe Now

Immuneering Corporation

Immuneering Reports First Patient Dosing with IMM-6-415 in the P-I/IIa Study for Treating Advanced Solid Tumors

Immuneering Reports First Patient Dosing with IMM-6-415 in the P-I/IIa Study for Treating Advanced Solid Tumors

March 28, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us